53.00
+0.60
+(1.15%)
At close: January 15 at 10:15:00 AM GMT+2
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Yoram Azulai | CFO, VP of Finance, Acting CEO & Company Secretary | 450k | -- | 1961 |
HBL - Hadasit Bio-Holdings Ltd
Jerusalem Bio-Park
5th Floor Hadassah Ein-Kerem Campus
Jerusalem, 91120
Israel
- Sector:
- Healthcare
- Industry: Biotechnology
Description
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
Corporate Governance
HBL - Hadasit Bio-Holdings Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
February 7, 2019 at 12:00 AM UTC
Ex-Dividend Date
Related Tickers
ENLV.TA Enlivex Therapeutics Ltd.
417.00
-2.23%
TSBX Turnstone Biologics Corp.
0.4600
+12.14%
MTVA MetaVia Inc.
1.9200
-2.06%
OKUR OnKure Therapeutics, Inc.
5.66
+1.43%
ABVC ABVC BioPharma, Inc.
0.5236
-1.86%
ELTX Elicio Therapeutics, Inc.
7.74
+7.50%
NVCT Nuvectis Pharma, Inc.
6.55
+9.17%
QTTB Q32 Bio Inc.
3.5200
+5.47%
CLDI Calidi Biotherapeutics, Inc.
0.7417
-2.54%
CRVO CervoMed Inc.
2.3100
+3.70%